Carmustine (BCNU) requires protection from what element during administration?

Carmustine (BCNU) is a chemotherapy agent that is sensitive to light. During administration, exposure to light can lead to the degradation of the drug, potentially reducing its efficacy. To ensure the maximum therapeutic potential and stability of Carmustine, it is crucial to protect it from light exposure. This practice typically involves using opaque bags or containers during preparation and administration.

Moisture, air, and cold temperatures are relevant considerations for many pharmaceuticals, yet they do not have the same critical impact on Carmustine's integrity as light does. Protecting Carmustine from light helps maintain its chemical stability and effectiveness in treating the intended conditions.